Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Cordoba
R
R
Ramirez
E
E
Lei
S H
SH
Lopez de la Guia
A
A
Sanjurjo
M J
MJ
Carcas
A J
AJ
Hernandez-Navarro
F
F
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000627:therapeutic use*; D017964:Itraconazole / Q000009:adverse effects* / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D017964:Itraconazole; D014212:Tretinoin; D000077211:Zoledronic Acid